SOPHiA GENETICS (SOPH) Long-Term Debt Repayments (2020 - 2021)
SOPHiA GENETICS recorded quarterly Long-Term Debt Repayments of -$2.9 million in Q2 2021, down 1037.11% quarter-over-quarter from -$256000.0 in Q1 2021.
SOPHiA GENETICS's Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at -$2.9 million for Q2 2021.
- In Q2 2021, Long-Term Debt Repayments changed N/A year-over-year to -$2.9 million; the TTM figure through Dec 2021 stood at -$3.2 million (changed N/A YoY), while the FY2021 annual figure was -$3.2 million, up 80.84% from the prior year.
- Long-Term Debt Repayments came in at -$2.9 million for Q2 2021 at SOPHiA GENETICS, down from -$256000.0 in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of -$256000.0 in Q1 2021 to a low of -$6.9 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 12.35 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 15.00 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 23.55 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | SOPHiA GENETICS | 24.12 Mn | -46.17 Mn | 14.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -2.91 Mn |
| Jun 30, 2021 | -2.91 Mn |
| Mar 31, 2021 | -256,000.00 |
| Mar 31, 2021 | -256,000.00 |
| Dec 31, 2020 | -2.35 Mn |
| Dec 31, 2020 | -2.35 Mn |
| Sep 30, 2020 | -6.89 Mn |
| Sep 30, 2020 | -6.89 Mn |